Construct: ORF TRCN0000476797

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF002246.1_s317c1
Derived from:
ccsbBroadEn_11582
DNA Barcode:
GACTTACTCCCCGGATCTCGTAGG
Epitope Tag:
V5
Notes:
No stop codon in insert

Originally Annotated References:

Gene:
LILRB3 (11025)

Vector Information:

Vector Backbone:
pLX_317
Pol II Cassette 1:
SV40-PuroR
Pol II Cassette 2:
EF1a-TRCN0000476797
Selection Marker:
PuroR
Visible Reporter:
n/a
Epitope Tag:
n/a

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 102725035 LOC102725035 leukocyte immunoglobulin-li... XM_006726314.4 99.9% 99.8% 863C>G
2 human 102725035 LOC102725035 leukocyte immunoglobulin-li... XM_006726313.4 99.7% 99.6% 863C>G;1591_1593delCAG
3 human 107987462 LOC107987462 leukocyte immunoglobulin-li... XM_017030297.1 98.8% 97.7% (many diffs)
4 human 107987425 LOC107987425 leukocyte immunoglobulin-li... XM_006726280.2 98.7% 97.6% (many diffs)
5 human 107987462 LOC107987462 leukocyte immunoglobulin-li... XM_017030296.1 98.6% 97.6% (many diffs)
6 human 11025 LILRB3 leukocyte immunoglobulin li... NM_006864.4 98.6% 97.3% (many diffs)
7 human 107987425 LOC107987425 leukocyte immunoglobulin-li... XM_006726278.2 98.6% 97.4% (many diffs)
8 human 11025 LILRB3 leukocyte immunoglobulin li... NM_001081450.3 98.5% 97.1% (many diffs)
9 human 102725035 LOC102725035 leukocyte immunoglobulin-li... XM_011548575.3 97.3% 97.2% 863C>G;1308_1358del
10 human 102725035 LOC102725035 leukocyte immunoglobulin-li... XM_011548574.3 97.1% 97% 863C>G;1308_1358del;1642_1644delCAG
11 human 11025 LILRB3 leukocyte immunoglobulin li... XM_017026223.1 96.8% 95.5% (many diffs)
12 human 11025 LILRB3 leukocyte immunoglobulin li... XM_017026222.1 96.6% 95.4% (many diffs)
13 human 107987462 LOC107987462 leukocyte immunoglobulin-li... XM_017030299.1 96.2% 95.2% (many diffs)
14 human 107987425 LOC107987425 leukocyte immunoglobulin-li... XM_011547051.3 96.1% 95% (many diffs)
15 human 107987462 LOC107987462 leukocyte immunoglobulin-li... XM_017030298.1 96% 95% (many diffs)
16 human 11025 LILRB3 leukocyte immunoglobulin li... NM_001320960.2 96% 94.7% (many diffs)
17 human 107987425 LOC107987425 leukocyte immunoglobulin-li... XM_011547050.2 96% 94.9% (many diffs)
18 human 107987425 LOC107987425 leukocyte immunoglobulin-li... XM_011547058.2 96% 94.7% (many diffs)
19 human 11025 LILRB3 leukocyte immunoglobulin li... XM_011526381.2 95.9% 94.6% (many diffs)
20 human 11025 LILRB3 leukocyte immunoglobulin li... XM_011526382.2 95.9% 94.4% (many diffs)
21 human 11025 LILRB3 leukocyte immunoglobulin li... XM_017026221.1 94.2% 93% (many diffs)
22 human 11025 LILRB3 leukocyte immunoglobulin li... XM_017026219.1 94.1% 92.9% (many diffs)
23 human 11025 LILRB3 leukocyte immunoglobulin li... XM_017026220.1 94.1% 92.7% (many diffs)
24 human 11025 LILRB3 leukocyte immunoglobulin li... XM_017026218.1 94% 92.6% (many diffs)
25 human 11025 LILRB3 leukocyte immunoglobulin li... XM_024451332.1 87.9% 86.5% (many diffs)
26 human 102725035 LOC102725035 leukocyte immunoglobulin-li... XR_001756785.2 84.7% (many diffs)
27 human 107987425 LOC107987425 leukocyte immunoglobulin-li... XR_952182.3 83.7% (many diffs)
28 human 107987462 LOC107987462 leukocyte immunoglobulin-li... XR_001756804.1 82.6% (many diffs)
29 human 10990 LILRB5 leukocyte immunoglobulin li... XM_011526361.2 81.3% 71.2% (many diffs)
30 human 10990 LILRB5 leukocyte immunoglobulin li... XM_011526360.2 79.4% 69.5% (many diffs)
31 human 10990 LILRB5 leukocyte immunoglobulin li... XM_011526359.2 79.3% 69.4% (many diffs)
32 human 10990 LILRB5 leukocyte immunoglobulin li... NM_001304457.2 78.3% 68.5% (many diffs)
33 human 10990 LILRB5 leukocyte immunoglobulin li... NM_006840.5 75.1% 64.9% (many diffs)
34 human 10990 LILRB5 leukocyte immunoglobulin li... NM_001081442.3 75% 64.8% (many diffs)
35 human 102725035 LOC102725035 leukocyte immunoglobulin-li... XR_001756784.2 74.9% (many diffs)
36 human 11025 LILRB3 leukocyte immunoglobulin li... XR_001753596.1 74.5% (many diffs)
37 human 79168 LILRA6 leukocyte immunoglobulin li... NM_001360167.1 72.4% 69.2% (many diffs)
38 human 79168 LILRA6 leukocyte immunoglobulin li... NM_024318.4 72.3% 69% (many diffs)
39 human 79168 LILRA6 leukocyte immunoglobulin li... XM_011547130.2 70.2% 66.4% (many diffs)
40 human 10990 LILRB5 leukocyte immunoglobulin li... XM_011526362.2 67.4% 59.4% (many diffs)
41 human 11025 LILRB3 leukocyte immunoglobulin li... NR_135493.2 67.4% (many diffs)
42 human 11025 LILRB3 leukocyte immunoglobulin li... NR_135495.2 65.3% (many diffs)
43 human 11025 LILRB3 leukocyte immunoglobulin li... NR_135496.2 65.1% (many diffs)
44 human 79168 LILRA6 leukocyte immunoglobulin li... NR_104098.2 64.4% (many diffs)
45 human 11025 LILRB3 leukocyte immunoglobulin li... NR_135494.2 63.2% (many diffs)
46 human 10990 LILRB5 leukocyte immunoglobulin li... NM_001081443.3 62.6% 54.3% (many diffs)
47 human 10288 LILRB2 leukocyte immunoglobulin li... NM_001278404.2 60.1% 53.2% (many diffs)
48 human 11006 LILRB4 leukocyte immunoglobulin li... NM_001278427.3 58.2% 50.3% (many diffs)
49 human 11006 LILRB4 leukocyte immunoglobulin li... NM_001278426.3 58.2% 50.3% (many diffs)
50 human 11006 LILRB4 leukocyte immunoglobulin li... NM_001278428.3 58.1% 50.2% (many diffs)
51 human 11006 LILRB4 leukocyte immunoglobulin li... NM_001278429.3 55.5% 45.8% (many diffs)
52 human 79168 LILRA6 leukocyte immunoglobulin li... XR_001756516.1 55.1% (many diffs)
53 human 11006 LILRB4 leukocyte immunoglobulin li... XM_017026217.1 54.8% 47.3% (many diffs)
54 human 11006 LILRB4 leukocyte immunoglobulin li... XM_024451331.1 54.8% 47.4% (many diffs)
55 human 11006 LILRB4 leukocyte immunoglobulin li... XM_017026216.1 54.7% 47.3% (many diffs)
56 human 11006 LILRB4 leukocyte immunoglobulin li... XM_017026215.1 54.6% 47.3% (many diffs)
57 human 107987441 LOC107987441 leukocyte immunoglobulin-li... XM_017030292.1 39.1% 39% (many diffs)
58 human 112268334 LOC112268334 leukocyte immunoglobulin-li... XM_024452538.1 39.1% 39% (many diffs)
59 human 112268336 LOC112268336 leukocyte immunoglobulin-li... XM_024452546.1 39.1% 39% (many diffs)
60 human 112268337 LOC112268337 leukocyte immunoglobulin-li... XM_024452551.1 39.1% 39% (many diffs)
61 human 112268340 LOC112268340 leukocyte immunoglobulin-li... XM_024452562.1 39.1% 39% (many diffs)
62 human 11006 LILRB4 leukocyte immunoglobulin li... NM_001278430.3 35.2% 26.9% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
69
ORF end:
1962
ORF length:
1893
Sequence:
1tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag
61ttggcaccat gacgcccgcc ctcacagccc tgctctgcct tgggctgagt ctgggcccca
121ggacccgcgt gcaggcaggg cccttcccca aacccaccct ctgggctgag ccaggctctg
181tgatcagctg ggggagcccc gtgaccatct ggtgtcaggg gagcctggag gcccaggagt
241accgactgga taaagaggga agcccagagc ccttggacag aaataaccca ctggaaccca
301agaacaaggc cagattctcc atcccatcca tgacagagca ccatgcgggg agataccgct
361gccactatta cagctctgca ggctggtcag agcccagcga ccccctggag ctggtgatga
421caggattcta caacaaaccc accctctcag ccctgcccag ccctgtggtg gcctcagggg
481ggaatatgac cctccgatgt ggctcacaga agggatatca ccattttgtt ctgatgaagg
541aaggagaaca ccagctcccc cggaccctgg actcacagca gctccacagt ggggggttcc
601aggccctgtt ccctgtgggc cccgtgaacc ccagccacag gtggaggttc acatgctatt
661actattatat gaacaccccc caggtgtggt cccaccccag tgaccccctg gagattctgc
721cctcaggcgt gtctaggaag ccctccctcc tgaccctgca gggccctgtc ctggcccctg
781ggcagagcct gaccctccag tgtggctctg atgtcggcta cgacagattt gttctgtata
841aggaggggga acgtgacttc ctccagcgcc ctggccagca gccccaggct gggctctccc
901aggccaactt caccctgggc cctgtgagcc gctcccacgg gggccagtac aggtgctatg
961gtgcacacaa cctctcctcc gagtggtcgg cccccagcga ccccctgaac atcctgatgg
1021caggacagat ctatgacacc gtctccctgt cagcacagcc gggccccaca gtggcctcag
1081gagagaacgt gaccctgctg tgtcagtcat ggtggcagtt tgacactttc cttctgacca
1141aagaaggggc agcccatccc ccactgcgtc tgagatcaat gtacggagct cataagtacc
1201aggctgaatt ccccatgagt cctgtgacct cagcccacgc ggggacctac aggtgctacg
1261gctcatacag ctccaacccc cacctgctgt ctttccccag tgagcccctg gaactcatgg
1321tctcaggaca ctctggaggc tccagcctcc cacccacagg gccgccctcc acacctggtc
1381tgggaagata cctggaggtt ttgattgggg tctcggtggc cttcgtcctg ctgctcttcc
1441tcctcctctt cctcctcctc cgacgtcagc gtcacagcaa acacaggaca tctgaccaga
1501gaaagactga tttccagcgt cctgcagggg ctgcggagac agagcccaag gacaggggcc
1561tgctgaggag gtccagccca gctgctgacg tccaggaaga aaacctctat gctgccgtga
1621aggacacaca gtctgaggac agggtggagc tggacagtca gagcccacac gatgaagacc
1681cccaggcagt gacgtatgcc ccggtgaaac actccagtcc TAGGAGAGAA ATGGCCTCTC
1741CTCCCTCCTC ACTGTCTGGG GAATTCCTGG ACACAAAGGA CAGACAGGTG GAAGAGGACA
1801GGCAGATGGA CACTGAGGCT GCTGCATCTG AAGCCTCCCA GGATGTGACC TACGCCCAGC
1861TGCACAGCTT GACCCTTAGA CGGAAGGCAA CTGAGCCTCC TCCATCCCAG GAAGGGGAAC
1921CTCCAGCTGA GCCCAGCATC TACGCCACTC TGGCCATCCA CTTGCCAACT TTCTTGTACA
1981AAGTGGTTGA TATCGGTAAG CCTATCCCTA ACCCTCTCCT CGGTCTCGAT TCTACGTAGT
2041AATGAACTAG TCCGTAACTT GAAAGTATTT CGATTTCTTG GCTTTATATA TCTTGTGGAA
2101AGGACGAGAC TTACTCCCCG GATCTCGTAG GACGCGTTAA GTCgacaatc aacctctgga
2161ttacaaaatt tgtgaaagat t

Download FASTA (ORF) (Full)

GPP Web Portal Terms of Service

Effective Date: December 8, 2025
By using this site, you agree to our terms and conditions below.

Overview of Terms

The data made available on this website were generated for research purposes and are not intended for clinical or commercial uses. Commercial use (or other use for profit-making purposes) of the GPP Web Portal and its tools, is not permitted under these terms and may require a separate license agreement from Broad or its contributors. For more information, please contact partnering@broadinstitute.org.

The original data may be subject to rights claimed by third parties, including but not limited to, patent, copyright, other intellectual property rights, biodiversity-related access and benefit-sharing rights. It is the responsibility of users of Broad Institute services to ensure that their use of the data does not infringe any of the rights of such third parties.

Any questions or comments concerning these Terms of Use can be addressed to: legal@broadinstitute.org.

By accessing and viewing this GPP Web Portal, you agree to the following terms and conditions:

Attribution

You agree to acknowledge the Broad Institute (e.g., in publications, services or products) for any of your use of its online services, databases or software in accordance with good scientific practice. You agree to use the acknowledgment wording provided for the relevant tools as indicated on the FAQ for each tool.

Updating the Terms of Use

We reserve the right to update these Terms of Use at any time. When alterations are inevitable, we will attempt to give reasonable notice of any changes by placing a notice on our website, but you may wish to check each time you use the website. The date of the most recent revision will appear on this, the "GPP Web Portal Terms of Use" page. If you do not agree to these changes, please do not continue to use our online services. We will also make available an archived copy of the previous Terms of Use for comparison.

Indemnification and Disclaimer of Warranties

You are using this GPP Web Portal at your own risk, and you hereby agree to hold Broad and its contributors and their trustees, directors, officers, employees, and affiliated investigators harmless for any third party claims which may arise from your use of the GPP Web Portal, the tools available therein, or any portion thereof. Further, you agree to indemnify Broad, its contributors, and its and their trustees, directors, officers, employees, affiliated investigators, students, and affiliates for any loss, costs, claims, damages, or other liabilities arising from any unpermitted commercial or profit-making use you make of the GPP Web Portal. The GPP Web Portal is a research tool and is provided "as is". Broad does not represent that the GPP Web Portal is free of errors or bugs or suitable for any particular tasks.

ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS ARE DISCLAIMED. IN NO EVENT SHALL BROAD OR ITS CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THE GPP WEB PORTAL, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

Governing Law

The terms and conditions herein shall be construed, governed, interpreted, and applied in accordance with the internal laws of the Commonwealth of Massachusetts, U.S.A. Furthermore, by accessing, downloading, or using the Database, You consent to the personal jurisdiction of, and venue in, the state and federal courts within Massachusetts with respect to Your download or use of the Database.